Company intelligence / Profile preview

Princeton Separations

Monmouth Junction, New Jersey, United Statesprinsep.com ↗

Ownership: Private
Employees: ~20
Development stage: Commercial

Overview

Princeton Separations is a family-owned biotechnology manufacturer specializing in molecular separation products for genomic and proteomic sample preparation. Their flagship Centri-Sep™ columns are industry standards for dye terminator removal in Sanger sequencing workflows, incorporated into protocols by major instrument providers such as Applied Biosystems/Thermo Fisher. The company has recently introduced new patented DNA size selection technologies (GeneStix™) to address evolving needs in high-throughput genomics.

Modalities: DNA purificationMolecular separations
Industry: Consumable Medical Devices

Partnerships

CliniSciences (distribution partnership announced)Applied Biosystems/Thermo Fisher (protocol integration partner/historical)

Beyond the preview

Go deeper on Princeton Separations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Princeton Separations.

Explore the full profile